CN Patent

CN1882327A — 含磷的新的拟甲状腺素药

Assigned to Metabasis Therapeutics Inc · Expires 2006-12-20 · 19y expired

What this patent protects

本发明涉及含有膦酸的拟T3药化合物、其立体异构体、可药用的盐、共结晶与前药和前药的可药用的盐和共结晶，以及它们的制备和在预防和/或治疗代谢病如肥胖症、NASH、高胆固醇血症和高脂血以及相关病症如动脉粥样硬化、冠心病、葡萄糖耐量降低、代谢综合征X和糖尿病中的用途。

USPTO Abstract

本发明涉及含有膦酸的拟T3药化合物、其立体异构体、可药用的盐、共结晶与前药和前药的可药用的盐和共结晶，以及它们的制备和在预防和/或治疗代谢病如肥胖症、NASH、高胆固醇血症和高脂血以及相关病症如动脉粥样硬化、冠心病、葡萄糖耐量降低、代谢综合征X和糖尿病中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN1882327A
Jurisdiction
CN
Classification
—
Expires
2006-12-20
Drug substance claim
No
Drug product claim
No
Assignee
Metabasis Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.